Study of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
Clinical trial NCT00312845 · COMPLETED
Trial details
- NCT number
- NCT00312845
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-03-01
- Primary completion
- 2010-06-01
- Enrollment
- 676
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.